LYMPHOMA COALITION
is a worldwide network of patient organisations with a full or partials focus on providing support to those affected by lymphoma, including chronic lymphocytic leukemia.
Find a Member Organisation Near YouSearch The Resource Library
Browse information on lymphoma diagnosis, treatment & survivorship
Today is #WorldBloodCancerDay.
Lymphoma is one of the most common types of blood cancer, affecting people, families and communities around the world. While every person’s experience is different, too many continue to face challenges with diagnosis, treatment access, emotional support and life beyond treatment.
At Lymphoma Coalition, we believe that people affected by lymphoma and CLL should have access to clear information, meaningful support and care that reflects their needs and experiences.
This World Blood Cancer Day, we stand with the global blood cancer community and recognize the importance of awareness, advocacy and collaboration in improving outcomes for all.
#WorldBloodCancerDay #BloodCancerAwareness #Lymphoma #CLL #PatientAdvocacy ... See MoreSee Less
Registration is open!
Join us on Monday, June 29 at 5:00 pm (ET) for our Answers from the Experts: Open Q&A with Drs. Jina Chung and Alison Moskowitz. We invite you to come prepared with any questions you may have or to sit in and listen. We hope you will plan to attend!
For more information and to register:
www.clfoundation.org/answers-experts-openqa-june
#CutaneousLymphoma #CutaneousLymphomaFoundation #CLFoundation ... See MoreSee Less
At the 52nd Annual Meeting of the EBMT, Lorna Warwick, CEO of Lymphoma Coalition, sat down with VJHemOnc to discuss findings from Lymphoma Coalition’s 2024 Global Patient Survey comparing shared decision-making experiences among patients with large B-cell lymphoma treated with stem cell transplantation versus CAR T-cell therapy.
The findings highlight gaps in communication, involvement in care decisions, and patient-provider relationships, particularly among patients who underwent stem cell transplantation.
🎥 Watch the full interview: www.youtube.com/watch?v=xm2x4qBT_0A&t=4s
📄 Read the abstract to explore the full findings and better understand how shared decision-making experiences differed by treatment: lymphomacoalition.org/variances-in-patient-experiences-with-shared-decision-making-by-treatment-i...
#Lymphoma #LBCL #PatientExperience #SharedDecisionMaking #CARTCellTherapy #EBMT2026 ... See MoreSee Less
Looking to stay up to date on the latest recommendations for Large B-cell lymphoma care?
A new episode of EHA Unplugged from the European Hematology Association explores the recently released EHA Clinical Practice Guidelines for Large B-cell lymphoma. In the episode, Prof Catherine Thieblemont and Prof Marie José Kersten, two key authors of the guidelines, discuss important recommendations across diagnosis, treatment, follow-up and supportive care.
The conversation offers a practical overview of what is changing, what clinicians should be aware of, and how the guidelines can support more informed, patient-centred care.
Listen to the EHA Unplugged episode to hear directly from guideline authors as they break down the key recommendations for LBCL care: tr.ee/nJ508tYW4E
Read the full EHA Clinical Practice Guidelines to explore the complete recommendations in detail: onlinelibrary.wiley.com/doi/10.1002/hem3.70207
Visit Lymphoma Coalition’s DLBCL page to learn more about diffuse large B-cell lymphoma: lymphomacoalition.org/diffuse-large-b-cell-lymphoma-dlbcl/
#Lymphoma #LBCL #DLBCL #BloodCancer #EHAUnplugged ... See MoreSee Less
THE RED THREAD
Inspired by Olivia Rodrigo's new song and music video "The Cure", Lymphoma Philippines is launching a new campaign to raise awareness of Lymphoma and blood cancers.
Join the #TheRedThread
#advocacy #Lymphoma
disclosure: Gemini was used in the creation of this photo ... See MoreSee Less
Access to essential medicines should not depend on where someone lives.
Yet, approximately 2 billion people worldwide still lack access to the essential medicines they need.
Lymphoma Coalition’s new report, Affordability, Accessibility and Equity of Essential Medicines for Lymphoma and CLL, examines the global challenges affecting the affordability, accessibility, and availability of essential medicines for lymphoma and CLL, including regulatory hurdles, drug shortages, inconsistent pricing, fragmented policies, and limited medicine availability across countries and regions.
Equitable access requires policies that address more than cost. It means supporting consistent, fair, and sustainable access to safe, effective, and quality medicines for all.
Download the report to explore the global challenges and policy actions shaping access to essential medicines for lymphoma and CLL.
lymphomacoalition.org/wp-content/uploads/Report-Card-EML_A4_Final.pdf
#Lymphoma #CLL #EssentialMedicines #HealthEquity #Policy ... See MoreSee Less